Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis

被引:51
作者
Pepper, C
Thomas, A
Tucker, H
Hoy, T
Bentley, P [1 ]
机构
[1] Llandough Hosp, Dept Haematol, Penarth, S Glam, Wales
[2] Univ Wales Coll Med, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales
关键词
apoptosis; annexin V; terminal deoxynucleotidyl transferase; 7A6; antigen; Apo2.7; antibody; B-cell chronic lymphocytic leukemia;
D O I
10.1016/S0145-2126(98)00013-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chlorambucil-induced apoptosis was assessed by three different flow cytometric methods in B-cell chronic lymphocytic leukaemia (B-CLL) cells cultured in vitro and the results were compared with those derived from the morphological assessment of the same samples. Spontaneous apoptosis was consistently observed in the control cultures in the absence of drug but this accounted for less than 12% of all cells in every case. The methods under investigation were the Annexin V labelling assay, the terminal deoxynucleotidyl transferase (TdT) end-labelling assay and the labelling of a 38 kDa mitochondrial membrane protein (7A6 antigen) which is exposed on cells undergoing apoptotic cell death (Apo2.7 assay). The Annexin V assay consistently stained a higher percentage of cells and with a greater separation between the positive and negative cell populations. We conclude that the phosphatidyl serine translocation to the outer leaflet of the cell membrane following an apoptotic signal, as labelled by Annexin V, probably occurs before the development of the DNA strand breaks or the exposure of 7A6 antigen in those cells triggered to die by apoptosis. (C) 1998 Elsevier Science Ltd. All rights
引用
收藏
页码:439 / 444
页数:6
相关论文
共 16 条
[1]  
BEGLEITER A, 1994, LEUKEMIA S1, V8, P103
[2]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[3]  
2-V
[4]   GUIDELINES FOR CLINICAL PROTOCOLS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - RECOMMENDATIONS OF THE NATIONAL-CANCER-INSTITUTE-SPONSORED-WORKING-GROUP [J].
CHESON, BD ;
BENNETT, JM ;
RAI, KR ;
GREVER, MR ;
KAY, NE ;
SCHIFFER, CA ;
OKEN, MM ;
KEATING, MJ ;
BOLDT, DH ;
KEMPIN, SJ ;
FOON, KA .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (03) :152-163
[5]  
GORCZYCA W, 1993, CANCER RES, V53, P1945
[6]  
HANADA M, 1993, BLOOD, V82, P1820
[7]   REVERSAL OF CHEMORESISTANCE OF LYMPHOMA-CELLS BY ANTISENSE-MEDIATED REDUCTION OF BCL-2 GENE-EXPRESSION [J].
KITADA, S ;
TAKAYAMA, S ;
DERIEL, K ;
TANAKA, S ;
REED, JC .
ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (02) :71-79
[8]  
KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327
[9]  
MIYASHITA T, 1992, CANCER RES, V52, P5407
[10]   Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia [J].
Pepper, C ;
Bentley, P ;
Hoy, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (03) :513-517